Cyclosporine A and Mycophenolate Mofetil Versus Cyclosporine A and Methotrexate for Graft Versus Host Disease Prophylaxis after Stem Cell Transplantation from HLA-Identical Siblings.
Frank Neumann(Beth Israel Deaconess Medical Center), Guido Kobbe(Düsseldorf University Hospital), Christoph Tapprich(Johnson & Johnson (Germany)), Thorsten Graef(Beth Israel Deaconess Medical Center), Ulrich Germing(Düsseldorf University Hospital), Matthias Vaupel(Heinrich Heine University Düsseldorf), Roland Fenk(Beth Israel Deaconess Medical Center), Rainer Haas(Heinrich Heine University Düsseldorf), Ulrich Steidl(Heinrich Heine University Düsseldorf)
Cited by 3
Related Papers
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation
|Blood|2014|400